BamSEC and AlphaSense Join Forces
Learn More

Channel Therapeutics Corporation

NYSE American: CHRO    
Share price (12/24/24): $0.63    
Market cap (12/24/24): $3.805 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 34 pages Chromocell Therapeutics Corporation Convertible Note
12/34/56
EX-4.2
from 10-K 3 pages Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from S-8 8 pages Chromocell Therapeutics Corporation 2023 Equity Incentive Plan Stock Option Agreement
12/34/56
EX-4.5
from S-8 9 pages Chromocell Therapeutics Corporation 2023 Equity Incentive Plan Restricted Stock Unit Agreement
12/34/56
EX-4.4
from S-8 1 page First Amendment to the Chromocell Therapeutics Corporation 2023 Equity Incentive Plan as Adopted by Resolution of the Board of Directors Effective as of February 14, 2024
12/34/56
EX-4.1
from 8-K 16 pages Underwriters’ Warrant Agreement
12/34/56
EX-4.34
from S-1/A 3 pages Stock Rescission Agreement
12/34/56
EX-4.33
from S-1/A 4 pages First Amendment to Senior Secured Convertible Note
12/34/56
EX-4.32
from S-1/A 4 pages Fourth Amendment to Senior Secured Convertible Note
12/34/56
EX-4.31
from S-1/A 6 pages Chromocell Therapeutics Corporation Fifth Amended and Restated Promissory Note
12/34/56
EX-4.30
from S-1/A 5 pages Indenture or similar
12/34/56
EX-4.1
from S-1/A 16 pages Underwriters’ Warrant Agreement
12/34/56
EX-4.29
from S-1/A 1 page Chromocell Therapeutics Corporation Amendment No. 1 to Promissory Note
12/34/56
EX-4.28
from S-1/A 8 pages Stock Issuance Agreement
12/34/56
EX-4.27
from S-1/A 4 pages Chromocell Therapeutics Corporation Second Amended and Restated Promissory Note
12/34/56
EX-4.26
from S-1/A 4 pages Chromocell Therapeutics Corporation Second Amended and Restated Promissory Note
12/34/56
EX-4.25
from S-1/A 4 pages Chromocell Therapeutics Corporation Second Amended and Restated Promissory Note
12/34/56
EX-4.24
from S-1/A 4 pages Chromocell Therapeutics Corporation Second Amended and Restated Promissory Note
12/34/56
EX-4.23
from S-1/A 6 pages Chromocell Therapeutics Corporation Fifth Amended and Restated Promissory Note
12/34/56
EX-4.22
from S-1/A 5 pages 3i, LP Re: Fourth Amended and Restated Promissory Note
12/34/56